Biotech

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Endometrial cancer data on Genmab’s Elahere rival beat forecast

The biotech reported a 50% unconfirmed response rate, beating the expectations of analysts to boost confidence ahead of a move into phase 3.
Nick Paul Taylor May 23, 2025 9:22am
Paraglider over Lake Tahoe

Weight of market pressures pushes Novo CEO out—Chutes & Ladders

May 23, 2025 8:30am
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Businessman climbing steps to pluck a star from the sky

Merus hails 'unprecedented' survival on solid tumor bispecific

May 23, 2025 7:35am
Guidehouses Karla Anderson shares top tips for successful biotech commercialization

Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization

Oct 28, 2024 8:00am
time minute

Innate says lymphoma data shows anti-KIR3DL2 antibody’s promise

May 23, 2025 5:13am